FDA Approves ALLEGRA-D ALLERGY AND CONGESTION — Chattem, Inc.

Chattem, Inc. has secured approval for the new combination form of ALLEGRA-D ALLERGY AND CONGESTION, featuring fexofenadine hydrochloride and pseudoephedrine hydrochloride, signaling a strategic move to expand its allergy portfolio and directly compete in the congested over-the-counter market.